Form 4: Zivo Bioscience Director Boosts Stake

Zivo Bioscience Director and 10% owner Laith L. Yaldoo acquired 15,322 shares of common stock at $15.99 per share.

Summary

• Laith L. Yaldoo, a Director and 10% owner of Zivo Bioscience, Inc. (ZIVO), purchased additional common stock.
• The transaction involved the acquisition of 15,322 shares of common stock.
• The shares were acquired at a price of $15.99 per share.
• Following this transaction, the beneficial ownership of common stock by HEP Investments LLC, an entity through which Mr. Yaldoo indirectly owns shares, stands at 573,436 shares.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a director and 10% owner increasing their stake, indicating strong insider confidence in the company's value and future.

Positives

• A Director and 10% owner increasing their stake in the company signals confidence in its future prospects and valuation.
• The purchase of 15,322 shares at $15.99 per share represents a significant investment by an insider.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider buying, particularly by a director and significant shareholder, is often interpreted by the market as a positive signal, suggesting that those closest to the company believe its stock is undervalued or poised for growth. This action can influence investor sentiment within the biotechnology or bioscience industry.

Related Party Transactions

• The acquisition of 15,322 shares of common stock was indirectly beneficially owned by HEP Investments LLC, an entity associated with the reporting person, Laith L. Yaldoo.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's prospects, potentially boosting investor confidence.
• The transaction could positively influence market perception of the company's stock.

Key Dates

Recommendation

The purchase of shares by a director and 10% owner, Laith L. Yaldoo, is a strong signal of insider confidence. Such an action suggests that management believes the company's stock is currently undervalued or has significant upside potential, making it an attractive investment opportunity.

Keywords

Zivo Bioscience, ZIVO, Insider Trading, Form 4, Stock Purchase, Director, 10% Owner, Laith Yaldoo, Equity Acquisition